Loading clinical trials...
Loading clinical trials...
The objective of this study is to compare the results of a deep learning approach to diabetic retinopathy assessment with results from (1) an in-person examination with an ophthalmologist, and (2) the...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Charles Drew University of Medicine and Science
Collaborators
NCT01496625 · Age-Related Macular Degeneration, Diabetic Retinopathy, and more
NCT06943599 · Age Related Macular Degeneration, Diabetic Retinopathy, and more
NCT06821399 · Diabetes, Diabetic Retinopathy, and more
NCT07425522 · Diabetic Macular Edema
NCT07308639 · Neovascular Age-related Macular Degeneration (nAMD); Diabetic Macular Edema (DME); Retinal Vein Occlusion (RVO)
Los Angeles Department of Public Health
Los Angeles, California
University of California - Los Angeles
Los Angeles, California
Charles R. Drew University of Medicine and Science
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions